nbi 27914 has been researched along with isoproterenol in 1 studies
| Studies (nbi 27914) | Trials (nbi 27914) | Recent Studies (post-2010) (nbi 27914) | Studies (isoproterenol) | Trials (isoproterenol) | Recent Studies (post-2010) (isoproterenol) |
|---|---|---|---|---|---|
| 76 | 0 | 29 | 30,780 | 803 | 2,640 |
| Protein | Taxonomy | nbi 27914 (IC50) | isoproterenol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.246 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.333 | |
| Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 1.77 | |
| Beta-1 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
| Beta-3 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
| Beta-2 adrenergic receptor | Canis lupus familiaris (dog) | 0.6667 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silberman, Y; Winder, DG | 1 |
1 other study(ies) available for nbi 27914 and isoproterenol
| Article | Year |
|---|---|
Corticotropin releasing factor and catecholamines enhance glutamatergic neurotransmission in the lateral subdivision of the central amygdala.
Topics: Adrenergic beta-Agonists; Amygdala; Aniline Compounds; Animals; Catecholamines; Corticotropin-Releasing Hormone; Dopamine; Excitatory Postsynaptic Potentials; Glutamic Acid; Isoproterenol; Male; Mice; Neurons; Peptide Fragments; Peptides, Cyclic; Pyrimidines; Receptors, Corticotropin-Releasing Hormone; Synaptic Transmission | 2013 |